AG
CERE

Algert Global’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Algert Global’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-39,742
Closed -$1.63M – 1667
2024
Q2 		$1.63M Buy
39,742
+7,312
+23% +$299K 0.05% 530
2024
Q1 		$1.37M Buy
32,430
+1,160
+4% +$49K 0.05% 532
2023
Q4 		$1.33M Buy
+31,270
New +$1.33M 0.05% 540